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Abstract
Introduction: Major abdominal aortic surgery requires significant fluid resuscitation in the
post-operative phase. Patients are at significant risk of perioperative morbidity and mortality
which can be affected by the approach to post-operative fluid resuscitation. Point of care
ultrasonography (POCUS) has evolved as a tool to perform whole-body assessments at the
bedside to augment the physical exam and guide the resuscitation of the critically ill. This
study will aim to explore the value of rigorous goal-directed resuscitation in aortic surgery
using point of care ultrasonography (POCUS).
Methods: In an open-label, randomized, feasibility trial we enrolled 17 patients to receive
resuscitation guided by either POCUS or usual care
Results: We observed that the trial protocol as designed met all of our pre-specified
feasibility metrics
Conclusion: The use of POCUS in guiding post-operative fluid resuscitation is feasible and
utilizing this protocol to design a study powered to detect statistically significant differences
in clinical outcomes is warranted.
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Summary for Lay Audience
Open abdominal aortic surgery for aortic aneurysms (an abnormal bulge that occurs in the
wall of the main major blood vessel that carries blood from your heart to the rest of the body)
or occlusive disease (a buildup of plaque that causes decreased blood flow from the aorta to
the rest of the body) represents a major surgery for patients. The care of patients after surgery
includes administration of intravenous (IV) fluids to support the blood pressure and perfusion
to the body’s major organs. There are risks that come with administering too much IV fluid
or too little in the post-operative period. This includes the risk of kidney injury from giving
too little fluid, or the risk of pulmonary edema (fluid accumulation in the tissue and air
spaces of the lungs) or congestive heart failure (fluid overwhelms the heart and causes it to
pump inefficiently) from giving too much fluid. The standard practice is for doctors to use a
combination of physical examination, urine output, and blood tests to guide the
administration of IV fluids after abdominal aortic surgery.
Portable ultrasound can be routinely used to assess heart and lung function at the bedside to
add additional information about a patient’s fluid balance and response to fluid
administration. This study used a protocol that compared the use of routine ultrasound of the
heart and lungs versus standard practice for the first 48 hours after open abdominal aortic
surgery. Since this is an innovative approach to taking care of post-operative patients this
study first examined whether the protocol we designed was both safe and feasible to carry
out. After enrolling 17 patients into the study, we found that all measures of safety and
feasibility were met. This now allows us to proceed with the design of a larger trial which
uses this same protocol to compare the ultrasound-guided care approach to the standard care
approach and see if we can detect any measurable difference in patient outcomes between the
two approaches.
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Chapter 1

1

Introduction

Open abdominal aortic surgery for reconstruction of aneurysmal and occlusive disease
imparts significant physiological stress which must be managed in the intraoperative and
post-operative period. One of the mainstays of postoperative management involves
judicious fluid administration in order to minimize the morbidity and mortality that
accompanies both over-resuscitation and under-resuscitation. A number of invasive and
noninvasive hemodynamic monitors have been used in this patient population to try and
augment decision making to effectively maximize the benefits and minimize the harms
during the post-operative resuscitation phase. The practice of critical care medicine has
recently seen a significant increase in the use of bedside Point-of-Care Ultrasound
(POCUS) for real-time hemodynamic assessments to gather both subjective and objective
data to aid diagnosis and management of the critically ill; however, this technology has
not been explored in the post-operative resuscitation of surgical patients.

1.1 Open Abdominal Aortic Surgery
Aneurysmal degeneration and occlusive atherosclerotic disease are two common
pathologies of the abdominal aorta requiring surgical intervention. While initially treated
with open surgical reconstruction1,2, the development of endovascular techniques has
introduced minimally invasive treatment options for both of these disease states.
Regardless, there continues to remain a role for open surgery in the treatment of
aneurysmal and occlusive disease of the abdominal aorta in modern vascular surgical
practice in patients with anatomy not suitable for endovascular therapy.
The incidence of abdominal aortic aneurysm (AAA) is approximately 2% in women and
5% in men over the age of 65, and the incidence increases by 6% for each additional
decade of life.3 In addition to gender and age the development of AAA is associated with
smoking history, hypertension, hypercholesterolemia, family history of AAA, coronary
artery disease (CAD), and peripheral vascular disease (PVD).4 As the diameter of an
aneurysm increases, the risk of rupture increases. For this reason, patients are offered
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surgery when the risk of rupture exceeds the risk of surgery. A number of studies have
adequately described the natural history of unrepaired AAA’s,5,6 and based on this natural
history data and the general perioperative risk of major complications, consideration for
repair is given for AAA’s greater than or equal to 5.5cm in size.7 Since the introduction
of Endovascular Aneurysm Repair by Dr. Juan Parodi in 19908 the use of Endovascular
Aneurysm Repair (EVAR) has been increasing and the use of open surgical repair (OSR)
has been decreasing in both the United States and Canada.9,10 Despite this, recent longterm data from high-quality randomized controlled trials has shown a mortality advantage
to open surgery after 8 years of post-operative follow-up11 leading many to reinforce their
belief that open surgical repair of AAA will continue to play a role in the future.
Aortoiliac occlusive disease represents a proximal anatomic location of peripheral
vascular disease. PVD is associated with smoking, hypertension, hypercholesterolemia,
and diabetes, though gender does not increase risk as it does in aneurysmal disease. 12,13
The anatomic diagnosis of PVD ranges from 1-22% depending on the population, risk
factors, and diagnostic techniques that are used.14 Anatomic disease may be
asymptomatic, or it may present with claudication and critical limb ischemia (rest pain or
lower extremity tissue loss and gangrene). Traditionally, patients are offered surgery for
lifestyle-limiting claudication or critical limb ischemia provided they are suitable
operative candidates. While recent developments in minimally invasive endovascular
techniques have resulted in improved long-term patency for high grade aortoiliac
occlusions,15,16 open surgical treatment with aortobifemoral bypass remains the gold
standard even in the modern endovascular era.17

1.2 Complications in Open Aortic Surgery
Open surgical reconstruction of the abdominal aorta results in significant impact on a
patient’s physiology both intraoperatively and post-operatively. In large population
studies, overall perioperative mortality for open aortic aneurysm repair approaches 4%.
Large cohorts assessing mortality of direct reconstruction of aortoiliac occlusive disease
also demonstrate mortality approaching 4%.18 Perioperative morbidity also remains high
in open aortic surgery, with the incidence of both minor and major perioperative
complications exceeding 20%.19,20 The effects of aortic cross-clamping on cardiovascular
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physiology21, the anatomic disruption of blood supply to the lower half of the body, and
the global effects of ischemia-reperfusion can manifest in multisystem insult. 19,22
Furthermore, a combination of intraoperative blood loss, pre-operative fasting, and
accumulation of fluid in extravascular spaces contribute to significant post-operative fluid
requirements. For this reason, post-operative fluid resuscitation plays a significant role in
minimizing the risks of morbidity derived from over and under-resuscitation of these
patients. Many of these complications are exacerbated by either too much or too little
fluid resuscitation immediately following open aortic surgery. Appropriate fluid
resuscitation to maintain adequate macrovascular perfusion of vital organs while avoiding
excess intra-cellular and interstitial edema is critical to preserving organ function and
avoiding these complications following aortic surgery.
Below is a list of some of the common complications of open aortic surgery for both
aneurysmal and occlusive disease:

1.2.1

Acute Kidney Injury

The risk of acute kidney injury (AKI) in open aortic surgery is related to the physiologic
derangement suffered by the patient during the post-operative recovery phase, as well as
technical and anatomic factors of the conduct of the operation itself.
The physiologic basis for acute kidney injury caused by transperitoneal open aortic
reconstruction occurs due to intravascular volume depletion from the cumulative effects
of multiple factors. Dissection of the retroperitoneal structures during the process of
aortic exposure results in disruption of lymphatic vessels as well as the release of
inflammatory mediators from local tissue injury. During the course of the operation the
viscera are exposed to the air resulting in measurable third space losses. Intraoperative
blood loss causes direct depletion of circulating blood volume. The effect of aortic crossclamping, as well as the resultant ischemia-reperfusion injury that follows has deleterious
effects on both myocardial function and the microcirculatory function of the renal
parenchyma. A decrease in intravascular volume activates neuroendocrine mechanisms
which ultimately lead to the decrease in the renal excretion of both sodium and free
water. The ultimate microcirculatory effects of these changes causes a net movement of
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water out of cells and capillaries to the interstitium which can lead to pre-renal acute
kidney injury.23,24
In addition to the physiologic factors mentioned above, there are several anatomic and
technical factors which can contribute to the incidence of AKI during open aortic surgery.
The level of aortic cross-clamping is directly related to the incidence of post-operative
AKI, with increasingly high rates of AKI seen when progressing from standard infrarenal
repair to thoracoabdominal aortic replacement.25,26 For aortic cross-clamping above the
level of the renal arteries, the duration of aortic cross-clamping and interruption of renal
blood flow is directly correlated to the rate of post-operative AKI.25 Exposure of the aorta
at the level of the renal arteries sometimes requires division of the left renal vein, and this
can contribute to rates of post-operative AKI.27,28 Manipulation of the aorta and renal
arteries in the presence of significant atherosclerotic disease can result in atheroembolism
causing post-operative AKI.29,30
The combined effects of these physiologic and anatomic contributors leads to an
incidence of post-operative AKI between 1 and 15% in contemporary series of open
infrarenal aortic surgery.9,17,19,31–35 Acute kidney injury is not always permanent as many
patients show renal recovery, and a minority of patients with acute kidney injury progress
to requiring permanent dialysis. More importantly, there is an association between higher
post-operative mortality in those experiencing post-operative renal failure25,31–37,37,38, and
as a result meticulous operative technique and judicious use of post-operative fluid
resuscitation are paramount to reducing both AKI and perioperative mortality.

1.2.2

Bowel Ischemia

Intestinal ischemia may occur after aortic surgery as a result of both patient and technical
factors. Ligation of the inferior mesenteric artery or internal iliac arteries, iliofemoral or
mesenteric occlusive disease, previous colonic resection, and a combination of preoperative comorbidities and post-operative hypotension and shock are known to be
associated with perioperative intestinal ischemia. The rates of bowel ischemia after
elective aortic surgery range from 1-3% in contemporary case series,39,40 though the
perioperative mortality of patients suffering bowel ischemia can be as high as 50%.41,42
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The rate of subclinical disease is higher, with rates of endoscopic and histologic findings
of 13% and 30% in the absence of clinical symptoms.43,44 For those patients that have
partial thickness ischemic colitis in the absence of intestinal gangrene and multiorgan
failure, broad spectrum antibiotics and aggressive correction of shock with volume
resuscitation and cardiac support are required for successful medical treatment to prevent
progression to full-thickness ischemia requiring bowel resection.

1.2.3

Limb Ischemia

Acute limb ischemia may occur as a result of open aortic reconstruction for aneurysmal
or occlusive disease. Routine assessment of lower extremity pulses both pre and postoperatively is important to monitor for the occurrence of this complication. Technical
anastomotic complications, vessel clamp injury, and acute thrombosis or
thromboembolism can all result in acute limb ischemia around the time of surgery. In
contemporary case series the rate of perioperative acute limb ischemia in open aortic
surgery approaches 2%.45 Similarly to the renal and mesenteric ischemia, patients
experiencing perioperative acute limb ischemia have overall higher rates of mortality.
Subclinical microscopic atheroembolic events are more common, but they are clinically
silent and can only be detected by hemodynamic vascular lab studies.46 Meticulous
operative technique and appropriate use of intraoperative anticoagulation are important in
the prevention of limb ischemia. In addition, the avoidance of significant post-operative
hypotension through appropriate resuscitation is important in avoiding thrombosis of
lower extremity arteries that have recently been manipulated during surgery.

1.2.4

Cardiac Complications

The major perioperative cardiac complications in patients receiving open aortic surgery
are myocardial infarction, arrhythmias, and congestive heart failure. Major randomized
trials of open vs. endovascular aneurysm repair demonstrate rates of major perioperative
cardiac morbidity of 2-3% in the open surgery group,47–49 but examination of registry
data and population studies show rates as high as 15%.50,51
The burden of cardiac disease is high in this patient population, with a historical cohort of
vascular surgery patients receiving pre-operative coronary angiography demonstrating
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that only 8% of patients were free of coronary artery disease.52 Intraoperatively,
application of an aortic cross-clamp causes a significant increase in myocardial oxygen
demand, and there is a significant increase in left ventricular (LV) afterload which
escalates the more proximal the clamp is applied. Subsequent ischemia-reperfusion of the
lower body causes myocardial suppression as the anaerobic metabolic byproducts are
released back into the systemic circulation. Resultantly, the incidence of perioperative
myocardial infarction in patients receiving open aortic surgery is as high as 10%.53 If
troponin rise is used as the definition alone, the rate of perioperative myocardial
infarction (MI) in patients receiving vascular surgery is as high as 24%.54
Congestive heart failure (CHF) is a common occurrence after open aortic surgery as well.
Both heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved
ejection fraction (HFpEF) are common in this population as a result of the burden of
ischemic heart disease or prolonged hypertension respectively. Patients are at risk of CHF
exacerbation (CHFe) in the perioperative period, as significant volume resuscitation is
often required to support the intravascular volume depletion and third-spacing of
intravascular volume that occurs as a result of the physiologic and anatomic insult of the
operation. Subsequently, the mobilization of body water from the third space back into
the intravascular circulating volume can sometimes overwhelm the heart in a patient with
pre-existing CHF leading to CHFe. CHF has been shown to be an independent predictor
of mortality in open aortic surgery.55 Furthermore, significant volume shifts can often
result in arrhythmias, such as atrial fibrillation from atrial stretch, which contribute to the
burden of perioperative morbidity.
Arrhythmias after vascular surgery are also common, and occur in up to 35% of patients
after open aortic surgery.55 Not all of these are benign electrocardiographic findings; one
study demonstrating an incidence of perioperative ventricular tachycardiac (VT) of 30%
in patients receiving open AAA repair, which was shown to be independently associated
with both cardiovascular events and sudden cardiac death during 24 months of postoperative follow-up.56 The rate of new-onset atrial fibrillation ranges from 3-10% in this
patient population, and it has been associated with longer hospital stay and higher 1-year
post-operative mortality.57–59 Arrhythmias such as VF and higher-degree AV blocks do
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occur and are often in the setting of acute myocardial ischemia/infarction as seen in the
general population.59

1.2.5

Respiratory Failure

Respiratory failure after open aortic surgery occurs as a result of both patient and
procedure-related factors. A recent systematic review and meta-analysis shows the
incidence of post-operative pulmonary complications to be 10%, with the most common
etiologies of respiratory failure being hypoxia, prolonged mechanical ventilation, and
pneumonia.60 Post-operative pulmonary complications have been shown to be associated
with higher rates of perioperative mortality in this study.
The most commonly contributing comorbidities are smoking and chronic obstructive
pulmonary disease (COPD) in this patient population. Among patients receiving open
aortic surgery 30-70% are current smokers, and over 90% of them have a history of
smoking at some point in their lifetime.17,61–63 The rates of COPD are correspondingly
high at 18-30%.17,62,63 Other patient-related risks for post-operative respiratory failure
include obstructive sleep apnea, congestive heart failure, and advanced age.60
Procedure-related risks also contribute to the likelihood of developing post-operative
respiratory failure. Known risks include open transabdominal aortic surgery,64,65 incisions
that extend close to the diaphragm,66 operative time >2 hours, emergency surgery,
perioperative blood transfusions, and prolonged post-operative intubation.65 These are
commonly applicable to patients receiving open abdominal aortic surgery. The use of
epidural analgesia intraoperatively as well as in the post-operative phase for analgesia
may be protective against the development of respiratory failure, but results are
heterogeneous.67–69 Consideration must be taken to avoid over-resuscitation in the postoperative phase, as iatrogenic volume overload can cause pulmonary edema resulting in a
risk for development of pneumonia and respiratory failure.

1.3 Point of Care Ultrasound
There are many tools available to assess hemodynamics to guide resuscitation; however,
tools such as central venous pressure and mixed central venous oxygen saturation70,
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pulmonary artery catheters3, and esophageal doppler probes71 are all invasive monitors
that carry with them a non-zero risk of complication during insertion and use. Noninvasive cardiac output monitors are also available, but some require peripheral arterial
lines for pulse contour readings, and non-invasive thoracic bioimpedance devices are
expensive and not readily accessible for use outside of operating rooms and intensive
care units.72
Point of Care Ultrasound (POCUS) involves the use of ultrasound at the bedside to
rapidly evaluate patient hemodynamics and diagnose cardiac, pulmonary, and intraabdominal pathology. Studies have successfully identified POCUS as a tool to narrow the
differential diagnosis in patients presenting with shock73, and to direct the approach for
resuscitation in critically ill patients in shock74,75,76. Furthermore, protocols have been
developed to explore a “whole-body” approach to bedside ultrasonography, which
involves ultrasound interrogation of the whole patient to augment data obtained by
history, physical exam, and laboratory investigations.77 A significant advantage inherent
in POCUS is the scalability of the examination; significant information can be obtained
from simple 2D images, and advanced hemodynamic data can be obtained using color
doppler, M-mode, and pulse-wave or continuous-wave doppler techniques as
indicated78,79.
In the post-operative patient, this approach to rapid, multi-system evaluation of the
patient with bedside ultrasonography has the potential to augment clinical data available
at the bedside. Often traditional endpoints of resuscitation such as vital signs, urine
output, and biochemistry can be misleading from confounders such as the use of epidural
catheters for post-operative analgesia80, ß-blockers and calcium-channel blockers81, and
pre-operative comorbid disease states. A focused examination of cardiac function, IVC
diameter, and lung function has the potential to diagnose patient volume status to help
guide post-operative resuscitation with fluids, vasopressors, and inotropes; furthermore, it
has the potential to diagnose pathology associated with over-resuscitation and underresuscitation, and guide patient management and the need for further investigation.
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1.3.1

Cardiac POCUS

Cardiac point of care ultrasound generally involves a 4-view focused cardiac ultrasound
to assess cardiac function. With these four basic views the scope of the exam can be as
limited or detailed as necessary to adequately answer the clinical question at hand. This
can range from simple 2D B-mode assessment for ventricular function or pericardial
effusion to full pulse-wave doppler assessment of stroke volume, cardiac output, and
valvular function. The complexity of the examination is flexibly scalable to the features
of the equipment used, the abilities of the operator, and the clinical question being
answered by the exam. The basic four views include the Parasternal long axis (Figure 1),
the Parasternal short axis (Figure 2), the Apical four chamber (Figure 3), and the
subcostal four chamber (Figure 4).
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Figure 1: Parasternal long-axis view. A. Transducer Position. B. Imaging Plane. C.
Cross-sectional anatomy. D. Ultrasound image. AO, aorta; AV, aortic valve; LA, left
atrium; LV, left ventricle; RVOT, right ventricular outflow tract; MV, mitral valve
Figure reprinted from Point of Care Ultrasound (p. 93), by Soni NJ, Arntfield R, and
Kory P. 2015, Philadelphia: Elsevier Saunders. Copyright ©2015 by Elsevier Saunders.
Reprinted with permission of Dr. Robert Arntfield, textbook author.
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Figure 2: Parasternal short-axis view. A, Transducer position. B, Imaging plane. C,
Cross-sectional anatomy. D, Ultrasound image. IVS, interventricular septum; LV, left
ventricle; PM, papillary muscle; RV, right ventricle.
Figure reprinted from Point of Care Ultrasound (p. 95), by Soni NJ, Arntfield R, and
Kory P. 2015, Philadelphia: Elsevier Saunders. Copyright ©2015 by Elsevier Saunders.
Reprinted with permission of Dr. Robert Arntfield, textbook author.
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Figure 3: Apical 4-chamber view. A, Transducer position. B, Imaging plane. C, Crosssectional anatomy. D, Ultrasound image. LA, left atrium; LV, left ventricle; MV, mitral
valve; RA, right atrium; RV, right ventricle; TV, tricuspid valve.
Figure reprinted from Point of Care Ultrasound (p. 97), by Soni NJ, Arntfield R, and
Kory P. 2015, Philadelphia: Elsevier Saunders. ©Copyright 2015 by Elsevier Saunders.
Reprinted with permission of Dr. Robert Arntfield, textbook author.
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Figure 4: Subcostal 4-chamber view. A, Transducer position. B, Imaging plane. C,
Cross-sectional anatomy. D, Ultrasound image. L, liver; LA, left atrium; LV, left
ventricle; MV, mitral valve; RA, right atrium; RV, right ventricle; TV, tricuspid valve
Figure reprinted from Point of Care Ultrasound (p. 100), by Soni NJ, Arntfield R, and
Kory P. 2015, Philadelphia: Elsevier Saunders. ©Copyright 2015 by Elsevier Saunders.
Reprinted with permission of Dr. Robert Arntfield, textbook author.
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1.3.2

Lung POCUS

Lung ultrasound provides utility in rapidly assessing the pleura, parenchyma, and
intrathoracic cavity at the bedside without the need for plain film x-ray, CT scan, or
magnetic resonance imaging (MRI). Similar to targeted cardiac POCUS exams, lung
pocus can serve to answer specific questions about the presence or absence of clinically
suspected pathology, or to help aid in diagnosis of someone with undifferentiated
respiratory failure. The BLUE protocol originally defined the four points of interrogation
of the chest wall to aid in identifying pleural and parenchymal pathology in a systematic,
organized fashion.82 (Figure 5) Using simple 2D B-mode ultrasound image interpretation,
a synthesis of the etiology of respiratory failure can be created from the images acquired
(Figure 6).
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Figure 5: BLUE lung exam points. Point 1 is located on the mid-clavicular line at
approximately the second intercostal space. Point 2 is located on the anterior axillary line
at approximately intercostal space 5, usually just lateral to the nipple in men. Point 3 is
located along the diaphragm in mid-axillary line. Point 4 is also called the posterolateral
alveolar pleural syndrome (PLAPS) point and is the most posterior point along the
diaphragm. Note the probe face is pointing to the sky with patient back rotated off the
bed.
Figure reprinted from Point of Care Ultrasound (p.55), by Soni NJ, Arntfield R, and
Kory P. 2015, Philadelphia: Elsevier Saunders. Copyright ©2015 by Elsevier Saunders.
Reprinted with permission of textbook publisher Elsevier Saunders.
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Figure 6: A sample of the correlation of specific findings on lung ultrasound to their
respective disease states.
Figure reprinted from Point of Care Ultrasound (p.68), by Soni NJ, Arntfield R, and
Kory P. 2015, Philadelphia: Elsevier Saunders. Copyright ©2015 by Elsevier Saunders.
Reprinted with permission of textbook publisher Elsevier Saunders.
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1.3.3

Inferior Vena Cava POCUS

The inferior vena cava (IVC) can be viewed with POCUS to aid in synthesizing
information about a patient’s volume status. Those with obviously low intravascular
volume will have a flat, depleted IVC whereas those that are volume replete or
overloaded will have a dilated, plethoric IVC. It can also aid in the diagnosis of other
disease states such as pericardial effusion causing tamponade, or right heart failure
depending on the IVC findings in the context of heart and lung POCUS studies. The
transverse diameter of the IVC can be easily measured from either a subcostal (Figure 7)
or transhepatic position (Figure 8).
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Figure 7: Subcostal inferior vena cava view. A, Transducer position. B, Imaging plane.
C, Cross-sectional anatomy. D, Ultrasound image. D, diaphragm; HV, hepatic vein; IVC,
inferior vena cava; L, liver; LV, left ventricle; RA, right atrium; RV, right ventricle.
Figure reprinted from Point of Care Ultrasound (p. 101), by Soni NJ, Arntfield R, and
Kory P. 2015, Philadelphia: Elsevier Saunders. Copyright ©2015 by Elsevier Saunders.
Reprinted with permission of Dr. Robert Arntfield, textbook author.
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Figure 8: Transducer position to acquire a transhepatic coronal view of the inferior vena
cava
Figure reprinted from Point of Care Ultrasound (p.138), by Soni NJ, Arntfield R, and
Kory P. 2015, Philadelphia: Elsevier Saunders. Copyright ©2015 by Elsevier Saunders.
Reprinted with permission of textbook publisher Elsevier Saunders.

1.4 Goal-Directed Resuscitation
The resuscitation and care of patients after open aortic surgery has historically involved
combining history, physical exam, vital signs, urine output, and laboratory biochemistry
to guide fluid resuscitation strategies and triage the need for further investigations.7
While studies have taken place in this patient population to determine whether fluid
liberal or fluid restrictive resuscitation strategies represent the ideal approach to postoperative care, the results have been largely heterogeneous.83,84,85,86,87,88 More recently,
this question was explored with a high quality randomized control trial when the RELIEF
trial examined the effects of liberal vs restrictive fluid administration in patients receiving
major abdominal surgery, which included patients receiving major vascular surgery.89
When considering the heterogeneity of results in this patient population, one can consider
if it is appropriate to group all patients into a single resuscitation strategy. The concept of
“goal-directed resuscitation”, first popularized by Rivers et al in the management of
septic shock90, has also been explored in the resuscitation of patients receiving major
open aortic surgery. Utilizing such tools as central venous pressure and mixed central
venous oxygen saturation70, cardiac output monitors with pulse contour to assess stroke
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volume variation72, pulmonary artery catheters3, and esophageal doppler probes71, benefit
has been shown in individualizing resuscitation strategies towards objective goals that
ensure balanced resuscitation without volume overload or excessive fluid restriction.
Larger systematic reviews have demonstrated potential benefit of goal-directed therapy in
a more generalized population of patients receiving major abdominal surgery.91,92

1.5 Determinants of Fluid Responsiveness
Post-operative management of patients receiving major abdominal aortic surgery
frequently includes the challenge of managing hypotension and intravascular volume.
While the goal of fluid resuscitation is to augment stroke volume in patients who are in
the early part of the Frank-Starling curve93, studies have demonstrated that only about
half of patients that are hemodynamically unstable and critically ill respond appropriately
to volume boluses94. Additionally, evidence suggests that over-resuscitation and volume
overload can lead to significant morbidity and mortality in multiple patient
populations95,96,97,98. In an attempt to appropriately identify patients that are volume
responsive and avoid the morbidity of continued fluid resuscitation in unresponsive
patients, clinical tools that predict volume responsiveness have been a subject of
significant clinical and academic interest.99

1.5.1

Central Venous Pressure

One of the earliest metrics for determining fluid responsiveness involved using a central
venous catheter to transduce a patient’s central venous pressure (CVP). Transducing both
the CVP in mmHg as well as a trend of the waveform provide information about venous
circulation and right heart function. CVP became widely used based on the assumption
that it was an adequate predictor of right ventricular (RV) preload, allowing clinicians to
approximate a patient’s trajectory on the frank-starling curve and subsequently predict
fluid responsiveness.100 While CVP has been explicitly explored in the goal-directed
resuscitation of patients receiving open abdominal aortic surgery70, there is robust
evidence suggesting it is a poor predictor of fluid responsiveness and therefore unreliable
to guide post-operative fluid management.101
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1.5.2

Pulmonary Artery Catheters

Pulmonary artery catheters similarly have been widely used in the past as real-time beatto-beat measures of right heart function with the ability to measure pulmonary artery
occlusion pressures and cardiac output by thermodilution. While these have been used in
goal-directed resuscitation of patients undergoing aortic surgery3, they have fallen out of
favor as regular monitors for post-operative hemodynamics owing to multiple studies
showing no difference in mortality as well as the potential for significant morbidity or
mortality with complications arising from their use.102

1.5.3

Systolic Pressure Variation, Pulse Pressure Variation, and
Stroke Volume Variation

Dynamic changes in an invasive arterial line waveform have also been used to assess
preload responsiveness, which are based on physiologic principles of the heart-lung
interactions during the respiratory cycle. Systolic pressure variation (SPV), pulse pressure
variation (PPV), and stroke volume variation (SVV) are three of these dynamic indices,
which are derived through computer-assisted analysis of different elements of the arterial
waveform throughout the cardiac cycle. A systematic review demonstrated that all three
are accurate predictors of fluid responsiveness with PPV being the most accurate
metric.94 Stroke volume variation has been examined as a metric of goal directed therapy
in patients receiving open abdominal aortic surgery with reasonable results.72 Pitfalls of
this technique include the fact that it requires patients to have an indwelling arterial
catheter which carries with it the risk of complications, commercial devices are required
to process the waveform to establish the desired index which carries with it an associated
cost, and the accuracy of a given index can be confounded by arrythmias, heart or lung
disease, and changes in ventilator mechanics.99

1.5.4

Non-Invasive Cardiac Output Monitors

The NICOMTM (Cheetah Medical, Portland, OR, USA) is a Non-invasive cardiac output
monitor relying on the principle of thoracic biorectance to measure cardiac output, and
has been shown to correlate with measurements obtained by pulse contour and
thermodilution.103 When combined with maneuvers such as a passive leg raise or a fluid
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bolus, the NICOM device has been shown to adequately predict volume
responsiveness.104 Like dynamic indices of arterial waveform variation, the NICOM
device requires special equipment for bioreactance measurements and analysis, although
it has the benefit of being noninvasive. It has yet to be evaluated in goal-directed fluid
resuscitation in patients receiving major aortic surgery.

1.5.5

Passive Leg Raise

The passive leg raise is a maneuver that can be performed at the bedside as a means of
assessing fluid responsiveness.105 The underlying principle involves consideration of the
venous volume present in the lower extremities as a reversible autotransfusion.
Assessment of hemodynamic effects after one minute of passive elevation of the legs can
provide insight into the patient’s fluid responsiveness, and ending the leg elevation
reverses the volume augmentation associated with the maneuver. It is often used in
conjunction with other monitoring devices such as arterial lines, PPV or SVV, or a
NICOM device to dynamically assess for the presence of hemodynamic changes during
the maneuver.99 The utility of the passive leg raise is limited by patients who do not have
intact lower extremities, those that cannot tolerate elevation of the legs to perform the
maneuver, and the effects of intra-abdominal hypertension restricting the ability of
venous return to reach the heart.

1.5.6

The Role of Ultrasound in Determining Fluid
Responsiveness

Assessment of the IVC with ultrasound has been another metric of great interest in
assessing both volume status and fluid responsiveness. Both absolute diameter of the
IVC, as well as respiratory variation in the diameter of the IVC can be used as metrics.74
The IVC can be used to obtain dynamic metrics of collapsibility of the IVC in
spontaneously breathing patients106 and distensibility of the IVC in mechanically
ventilated patients with positive pressure ventilation107. Assessment of these variations in
IVC have been proposed as a surrogate for fluid responsiveness, although there has been
some heterogeneity in the literature and varied degrees of acceptance as to the utility of
this metric in varying patient populations.108
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Transthoracic ultrasonography of the lung can elucidate a number of different
pathological states including pneumothorax, pleural effusion, pulmonary infection, and
pulmonary edema from volume overload.109 While the application of lung ultrasound for
identification of etiology of undifferentiated respiratory failure is well described 82, it can
also serve as a useful adjunct for decision making about volume status. In patients with
sonographic findings of extravascular lung water in the form of pulmonary edema or
pleural effusion based on the presence of “B-lines” suggesting parenchymal pathology,
and pleural fluid at dependent areas, synthesis of volume overload can be enhanced
through assessment of the lung fields with ultrasound.74
Routine assessment of left ventricular function can be performed using point of care
ultrasound to integrate a picture of volume status and volume responsiveness at the
bedside. Using a focused point-of-care qualitative assessment of LV function examining
endocardial excursion, myocardial thickening, and septal motion of the anterior leaflet of
the mitral valve, one can broadly categorize LV function as being hyperdynamic, normal,
reduced, or severely reduced.110,111 This data can be synthesized into an assessment of
volume status, volume responsiveness, and identifying patients whose hypotension would
be better treated with vasopressors or inotropes.
While the landscape of assessment of volume responsiveness has explored many
techniques and tools, the pitfalls associated in the limitations of their accuracy and the
invasive or expensive nature of the tools used to assess hemodynamics has limited their
widespread adoption. Ultrasound provides the potential for a comparatively cheap,
readily available, portable device that allows for a whole-body assessment of volume
status and fluid responsiveness to augment the ability for physicians to make timely,
insightful, and goal-directed resuscitation decisions at the bedside.

1.6 Study Rationale
There are numerous different post-operative complications associated with open
abdominal aortic surgery, and the rate of complications is high given the nature of the
surgery and the high-risk patient population involved. While attention to intraoperative
approach and technique is an important part of minimizing complications, attention to
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appropriate post-operative resuscitation and medical management of these patients is
important as well in working toward minimizing the myriad of complications
contributing to their perioperative morbidity and mortality. This combination of relatively
high-risk surgery in high-risk patients makes an ideal population to develop a
resuscitation strategy aiming to minimize the iatrogenic sequelae of over and underresuscitation in the post-operative phase.
Instead of contemplating fluid liberal versus fluid restrictive resuscitation strategies, a
more objective and clinically sound approach is to consider individualized resuscitation
strategies for each patient. While this has been historically attempted with older and more
invasive devices such as pulmonary artery catheters and esophageal doppler probes, these
devices are costly, disposable, and limited to use in the operating room or intensive care
unit.
To date no one has attempted a goal-directed resuscitation strategy guided by point of
care ultrasound in surgical patients. Ultrasound as a tool has become progressively more
democratized with the passing of time as devices have become less costly and more
affordable, culminating in personal ultrasound probes that attach to a smartphone or
digital tablet which are currently available on the market today. This has expanded the
role of ultrasound for use in regular bedside assessments as a more high-tech stethoscope.
POCUS has the potential to significantly augment the ability to perform personalized,
goal-directed resuscitation at the bedside in this patient population by virtue of being
cost-effective, non-invasive, easily reproducible, and its ability to rapidly synthesize
information about the heart, lungs, and IVC together with a bedside clinical assessment
with an aim to more accurately gauge intravascular volume and cardiac function.

1.7 Aim of the Study
This study will aim to examine the utility of using POCUS to assess cardiac function,
pulmonary function, and volume status via Inferior Vena Cava assessment as a tool to
provide individualized, goal-directed resuscitation after open aortic surgery. The potential
benefits of this approach to post-operative care would include optimizing use of fluid
liberal or fluid restrictive strategies when appropriate, selectively utilizing vasopressors
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or inotropes when appropriate, and personalizing resuscitation strategies to prevent
morbidity from over-resuscitation such as CHF, MI, and pulmonary edema, in addition to
preventing morbidity from under-resuscitation such as acute kidney injury, limb
ischemia, and bowel ischemia. To serve as a foundation for this investigation, we
designed a feasibility study using an open label, randomized controlled trial. The first
group received routine post-operative care guided by vital signs, biochemistry, and
patient physical exam to guide resuscitation. The second group received regular POCUS
assessments over the first 48 hours after surgery with a protocol designed to adjust the
resuscitative strategy from either fluid restrictive or fluid liberal depending on the on the
ultrasound findings.

1.8 Research Questions
The following research question was posed in conducting this study:
1. Is the protocol for goal-directed resuscitation using point-of-care ultrasound in
patients receiving open abdominal aortic surgery feasible to execute in the clinical
environment of our tertiary care Vascular Surgery program at Victoria Hospital,
London Health Sciences Center.
Answering this research question will allow us to determine whether it is appropriate to
consider further expanding this study into a trial adequately powered to detect a
difference in key clinical endpoints, or whether modifications will be necessary before
doing so.

1.9 Hypothesis
We hypothesize that the protocol for goal-directed resuscitation outlined in this trial will
be feasible to implement at our tertiary care center.
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Chapter 2

2

Study Design and Methodology

Patients assessed for elective open abdominal aortic surgery for both aneurysmal and
occlusive disease either as inpatients or in the outpatient vascular surgery clinic were
screened for eligibility at the time of initial consultation. Once the patient had been
screened for eligibility, participants were enrolled on the basis of informed consent with a
letter of information. The study was designed as an open-label 1:1 feasibility trial with
the primary endpoints reflecting feasibility of executing the trial protocol. Randomization
was performed in the REDCapTM database software using permuted block randomization
with block sizes of 2 and 4. Randomization took place after the completion of the
operation before the patient was transferred to the post-operative recovery area. Patient
baseline characteristics were reviewed and input into REDCapTM, and patients were only
randomized if they met the inclusion criteria and did not meet any of the exclusion
criteria.
The intervention arm involved randomization to POCUS-based management for goaldirected post-operative resuscitation for the first 48 hours of admission, whereas the
control group received management by usual care for the first 48 hours of admission
(figure 9). Patients randomized to POCUS received a focused cardiac, thoracic, and IVC
study performed post-operatively in the surgical recovery room, as well as scheduled
assessments on the inpatient ward in the morning and afternoon of post-operative day one
and two.
The protocol for the intervention group included a 4-view transthoracic echocardiogram
including the following views: Parasternal long axis, parasternal short axis, apical 4chamber, and supplemental subcostal short-axis and subcostal 4-chamber if parasternal
views were limited. Color Doppler was permitted for qualitative valvular assessment if
indicated. A longitudinal IVC view was attempted in the usual subcostal transabdominal
position, or the transhepatic position if the transabdominal view was not technically

27

feasible. A thoracic lung ultrasound study assessed the left and right anterior chest wall,
anterior axillary regions, as well as the costophrenic angle and posterolateral regions.

Figure 9: Flow diagram of participants in the study after randomization
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Participants randomized to the point of care ultrasound arm also had access to routine
avenues of patient assessment which included review of vital signs, biochemistry, and
urine output as well as bedside physical exam. Images acquired were reviewed for quality
assurance by sonographic experts with expertise in bedside point of care
echocardiography through a central image reporting system.
Point of care studies synthesized cardiac, thoracic, and IVC views to elucidate whether
patients were fluid deplete or fluid replete and if ventricular dysfunction was contributing
to hypotension or end-organ dysfunction. Based on this conclusion patients were
allocated to either a fluid restrictive or fluid liberal management strategy at each time
interval. The fluid liberal strategy consisted of fluid infusion of 2ml/kg/hr of balanced
crystalloid solution. For patients with a body weight greater than 100kg, fluid volumes
were calculated based on a maximum body weight of 100kg. The fluid restrictive strategy
consisted of a fluid infusion of 0.8ml/kg/hr of balanced crystalloid solution designed to
approximate euvolemia. IV boluses of crystalloid were permitted to treat hypotension
with Systolic Blood Pressure (SBP) <90mmHg with clinical signs of hypovolemia, but
oliguria was not used as a trigger for fluid bolus or titration of fluid infusion rates. Blood
transfusions were permitted to treat post-operative bleeding or anemia as clinically
indicated, with indication for transfusion set at a hemoglobin of 70g/L. Those with
severely decreased LV function who were presumed to be hypotensive secondary to poor
cardiac output were transferred to an appropriate level 1 care monitored bed to receive
vasopressors or inotropes to manage their hypotension. In addition to vasopressors they
would receive fluid restrictive resuscitation with an infusion rate of 0.8 ml/kg/hr of
balanced crystalloid solution. A visual summary of the goal-directed protocol is provided
in figure 10.
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Figure 10: Protocol for POCUS goal-directed resuscitation
*Adapted from C. Lee et all, 2016 74
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Participants randomized to the control group for usual care underwent resuscitation
guided by conventional means which included both static and dynamic measures such
review of vital signs, biochemistry, and urine output as well as the bedside physical
exam. In this arm patients did not undergo POCUS during their admission. IV fluid
infusion rates as well as targets for IV boluses were left to the discretion of the attending
physician and included hypotension, hypovolemia, as well as oliguria. Blood transfusion
was permitted for post-operative bleeding or anemia as clinically indicated, with
indication for transfusion set at a hemoglobin of 70g/L.
The protocol did not restrict formal radiographic or ultrasound studies such as plain film
x-rays, CT, MRI, echocardiography, abdominal ultrasonography, and duplex ultrasound
of lower extremity veins in patients in the intervention or control groups with appropriate
clinical indications.
Given that the point of care ultrasound arm involved using a portable ultrasound machine
to directly acquire images and the usual care arm involved physical examination and
interpretation of vital signs, urine output, and biochemistry, it was not be possible to
blind participants. It was also not possible to blind practitioners in this trial. Data
acquisition, interpretation, and implementation of a care plan based on the interventions
of the trial was done by the surgical team as well as the POCUS practitioners. As a result,
medical practitioners involved in patient care were aware of the allocation of their
patients. After the initial two days both groups were treated equally based on the
trajectories established during their first two post-operative days.
The inclusion criteria were focused to a specific patient population, which was intentional
in its design to augment its external validity. We anticipated that randomization would
balance the etiology of the aortic disease, patient comorbidities, and nature of surgical
reconstruction adequately.
Inclusion Criteria:
-

Patients must be 18 years of age or older.
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o There is no upper age limit for eligibility in this study.
-

Elective surgical procedures

-

Patients enrolled must be receiving open abdominal aortic surgery for either
occlusive disease (aortobifemoral bypass, transaortic endarterectomy) or aneurysmal
disease (infrarenal, juxtatrenal abdominal aortic aneurysms).

-

Patients must be deemed suitable operative candidates for open abdominal aortic
surgery as decided upon by the surgical and perioperative medicine assessments.

Exclusion Criteria:
-

Thoracoabdominal aneurysms (Type IV or larger extent)

-

Hybrid procedures (Requiring both endovascular and open surgical reconstruction)

-

American Society of Anesthesiologists physical status class 5 identified

-

Chronic renal failure requiring dialysis

-

Inability of patient or substitute decision maker to consent to study

2.1 Feasibility Study Rationale
A feasibility trial was selected for this study design given the gap in knowledge with this
specific research question, the infrastructure required to execute the protocol as designed,
and the multi-disciplinary nature of the protocol.

While the previous literature review outlined the body of evidence characterizing the use
of goal-directed resuscitation in the care of patients receiving open abdominal aortic
surgery as well as the use of point-of-care ultrasound as a tool for guiding patient care
decision in critical care, the synthesis of POCUS, goal-directed resuscitation, and the care
of post-operative patients has not been explored in the literature previously. Assumptions
being made in addressing this knowledge gap include presumption that using a goaldirected protocol of POCUS-guided resuscitation would be similar to goal-directed
approaches using metrics from invasive monitors, that the utility of POCUS in the care of
patients in critical care and emergency medicine suggests POCUS as a tool has similar
potential in the care of the post-operative patient, and that the integration of POCUS in
the daily workflow and clinical care of patients in critical care and emergency medicine
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implies this model will also be successful in the surgical inpatient care setting. In an
effort to explore the validity of these assumptions before embarking upon a study
powered to detect clinical significance, a feasibility trial was selected to evaluate these
assumptions objectively.
In addition to addressing the knowledge gap present with this clinical question, there
existed some uncertainty about the technology and infrastructure required to support this
study. While in isolation there may have been clinical utility to performing a POCUS
exam on these patients in the post-operative setting, the reality of executing these exams
in a clinical scenario carries with it certain specific challenges. Would the patients have
adequate anatomical windows to obtain ultrasound images in the post-operative period?
Would post-operative pain prohibit complete ultrasound examinations? Would the
ultrasound devices be reliable enough to work consistently? Could the studies be
completed in a reasonable amount of time such that obtaining the additional ultrasound
information would not disrupt clinical workflow? Would the protocol as designed
produce images that were actionable or clinically meaningful in this patient population?
Would the central image reporting system function as expected in a timely and efficient
manner? A feasibility trial was best equipped to answer these questions before embarking
on a larger study powered to detect clinical significance.
Finally, the multi-disciplinary nature of executing a study such as this warranted a
preliminary exploration with a feasibility trial in order to identify barriers to success at
the provider level. Even if the physiologic principles of the protocol were found to be
sound, it depended on the successful adherence to the protocol from surgeons, surgical
trainees, intensive care staff, and nurses working to take care of these patients in surgical
recovery, inpatient wards, and intensive care. In successfully examining barriers to
protocol adherence in a feasibility trial, the impact of non-adherence could be objectively
evaluated and strategies could be established to overcome these barriers before
proceeding with a larger study. This study also looked at any changes that may need to be
made to the protocol and POCUS assessments to make them as clinically meaningful and
parsimonious as possible before implementation in a larger evaluative trial.
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In addition to addressing the aforementioned issues, two important questions remained
when designing this study: What sample size is adequate to explore the feasibility
outcomes selected, and what are the criteria or thresholds for success for these outcomes?
Answers to these questions were found in the work of health research methodologists.
While guidance exists to estimate sample size based on effect size estimated from a main
trial’s design or from previous literature112, the novel nature of this intervention in this
population limited this more objective approach to sample size estimation. There exists
evidence that the precision about the mean and variance plateaus at a sample size of 12
per group in a feasibility study 113. With this in mind, coupled with the fact that papers
assessing goal-directed resuscitation in patients receiving aortic surgery demonstrated
statistical significance with sample sizes between 50 and 100, we conservatively selected
a sample size of 20 patients per arm in our study for a sample size of 40.

2.2 Primary Feasibility Endpoints
The primary outcomes centered around 30-day outcomes assessing the feasibility of
executing the trial protocol in this patient population. The pre-defined threshold for
feasibility is identified for each metric below.
-

Recruitment – consent rate of eligible patients as per inclusion/exclusion criteria ≥80% of patients

-

Successful randomization – Patients appropriately subjected to randomization at the
completion of operation - ≥80% randomized

-

Point of Care Ultrasound Completion – Studies successfully completed at intervals
defined by trial protocol – ≥80% completed
o Image Acquisition Adequate - Summary of quality review of images labelled
as “No concerns, standards met with improvement suggestions, standards met
with concerns, standards not met with serious concerns”. Agreement defined
by studies that meet targets of “standards met with improvement suggestions”
or greater. - ≥80% adequate
o Image Interpretation Adequate - Summary of quality review of images
labelled as “No concerns, standards met with improvement suggestions,
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standards met with concerns, standards not met with serious concerns”.
Agreement defined by studies that meet targets of “standards met with
improvement suggestions” or greater. ≥80% adequate
-

Protocol adherence – Patients appropriately receive fluid liberal or restrictive
resuscitation as defined by the protocol in response to POCUS findings - ≥80%
adherence

-

Successful Data Collection – All required data points are collected as defined in the
trial protocol - ≥80% of patients with complete data points

-

Contamination rate – Patients are withdrawn from the study protocol or crossed over
into the opposite arm of the study based on patient or physician motivators - ≤20%
contamination

2.3 Secondary Outcomes
Secondary outcomes of interest included the following clinical endpoints measured up to
30 days post operation. While the trial was not be adequately powered to detect
differences in these endpoints, they were collected to assist in development of further
phases of this study in the event of successful execution of the feasibility trial.
-

Myocardial infarction – Troponin elevation + Electrocardiogram (ECG) changes

-

Pneumonia – Symptoms + Chest x-ray/Lung Ultrasound findings

-

Surgical site infection – Purulence, positive wound culture

-

Pulmonary edema – Chest x-ray/Lung US findings + increasing oxygen requirement
in the absence of pneumonia

-

Acute kidney injury (RIFLE stage 2 – creatinine doubling from baseline)

-

Cardiac arrhythmia – as defined by bedside telemetry or ECG

-

Ischemic bowel – Radiographic, endoscopic or surgical findings

-

Unplanned admission to an Intensive Care Unit (ICU)

-

Death

-

Renal replacement therapy (Peritoneal dialysis or Hemodialysis)

-

Limb ischemia requiring anticoagulation or re-operation – defined clinically or
radiographically

-

Unplanned re-operation
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-

Total volume of crystalloid received during admission

-

Use of vasopressors or inotropes

-

Length of hospital stay

-

Length of ICU stay

-

Number of ventilator days

-

Inflammatory markers (C-reactive protein (CRP) at 24 hours post-operative)

-

Tissue perfusion markers (peak plasma lactate within 24 hours of operation – taken at
6 and 24 hours)

-

Post-operative blood product transfusions (Packed cells, platelets, Fresh frozen
plasma (FFP), cryoprecipitate)

2.4 Statistical Analysis
The feasibility outcomes will be analyzed using descriptive statistics as follows:
Recruitment – Overall proportion of eligible patients successfully entered into the study
divided by the total number of eligible patients consented and retained to full data
completion
Successful randomization – Overall proportion of consented patients successfully
receiving randomization at the completion of operation divided by the total number of
consented patients
POCUS study completion – Overall proportion of completed studies divided by expected
studies
Image quality – Proportion of agreement between physicians performing POCUS and
experts auditing studies will be measured for both image acquisition and interpretation –
threshold for quality ≥80% for acquisition and interpretation, measured separately
Protocol Adherence – Overall proportion of patients adequately receiving treatment as
defined by the trial protocol divided by the total number of patients enrolled
Successful Data Collection – Proportion of patients with no absent data points in the
database divided by the total number of patients enrolled
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Contamination rate – The number of patients withdrawn or crossed over into the opposite
arm of the study based on patient or physician motivators divided by the total number of
patients enrolled
Clinical outcome data will be collected as defined in the secondary outcomes with an
understanding that the trial will not be adequately powered to detect a difference in these
metrics, but to assist in developing the future trial should this protocol be feasible. No
data analysis will be performed on these metrics as a result.

2.5 Ethics Approval
This study received approval from the Western University Research Ethics Board. All
patients involved in the study received a consent form and letter of information with
specific attention paid to their freedom to withdraw from the study at any time with no
adverse effects on the care they were receiving.
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Results

After obtaining ethics approval and successfully registering the study with
clinicaltrials.gov (NCT #04180553) recruitment actively began in January of 2020. The
duration of recruitment of the study was three months from January to March of 2020. At
this time the global Covid-19 pandemic resulted in temporary cessation of recruitment of
further patients into the study. The reasons for this were twofold: All research activity at
our institution was halted to limit unnecessary exposure of research personnel to the
hospital environment and to allocate resources for clinical investigation into Covid-19
patients, and also because elective surgery was put on hold thus rendering our patient
population unavailable for clinical investigation during the pandemic. As a result data
available on the 17 patients successfully recruited into the study will be reported in
aggregate with plans to continue recruitment to the planned cohort of 40 patients once
full clinical and research duties resume at our institution (figure 11). Demographic data of
the cohort to date is outlined in table 1.
Expected rate of recruitment was 2 patients per week, with an estimated recruitment
period of 5 months to achieve a cohort of 40 patients. Up until the time of the Covid-19
pandemic, the observed rate of recruitment matched this estimate and study completion
was expected to meet the planned timeline (figure 12).
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Figure 11: Timeline of patient involvement from the time of recruitment to final data
analysis
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Characteristic
Median age (years)

Total Cohort (n = 17)
67 (Range 55-92)

Sex
Male

14 (82%)

Female

3 (18%)

Mean BMI (kg/m2)

28 (± 6.6)

ASA Score
1

0

2

0

3

2 (12%)

4

15 (88%)

Hypertension

9 (59%)

Heart Failure (LVEF < 35%)

1 (6%)

CKD Stage 3-5

0

Diabetes

3 (18%)

COPD

7 (41%)

Stroke/TIA

5 (29%)

Coronary Artery Disease

4 (21%)

Previous Coronary Artery Bypass

1 (6%)

Previous Coronary Artery Stenting

9 (59%)

Current Smoker

3 (18%)

Table 1: Baseline patient characteristics of the recruited patient cohort.
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Figure 12: Rate of observed recruitment plotted against rate of expected recruitment of
two patients per week. Cessation of observed recruitment coincided with initiation of
covid-19 pandemic planning at our center.
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3.1 Primary Feasibility Endpoints
Examining the primary endpoints of the cohort recruited to date demonstrates generally
favorable metrics of feasibility (table 2). To date all metrics have met the pre-defined
thresholds of feasibility. While definitive comments on the success of the feasibility trial
will await the full cohort, commentary on trends or implications of the interim cohort
accompany the analysis of each individual metric in the discussion below.

Feasibility Metric

Result

Recruitment

17 (89%)

Successful Randomization

17 (100%)

Ultrasound Studies Completed

40 (100%)

Ultrasound Image Quality Adequate

39 (98%)

Ultrasound Image Interpretation

40 (100%)

Adequate
Protocol Adherence

14 (82%)

Successful Data Collection

16 (94%)

Contamination Rate

0

Table 2: Summary of outcomes of the primary feasibility endpoints of the recruited
cohort
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3.1.1

Recruitment

Generally, the patients had favorable reception to the proposed investigation. Patients
were given adequate time to review the letter of information, and they were assured that it
was not mandatory for them to come to a decision at the time of initial consultation for
surgery. Out of a total of 19 patients who met the pre-defined inclusion criteria without
meeting any exclusion criteria, 17 were successfully recruited into the study to its
completion for a recruitment rate of 89%. Of the two patients who declined to consent for
the study, one cited their anxiety at the seriousness of the operation and their desire to
just see it through with as uncomplicated a plan of post-operative care as possible, and
the other expressed hesitation at “being part of an experiment” with an untested protocol.
Once patients were recruited into the study, none asked to be withdrawn during the
course of their inpatient stay after completion of their elective surgery. Despite our
concerns that perioperative discomfort and disruption of patient rest and recovery would
possibly affect patients’ desire to remain in the study, it did not have an adverse effect on
this interim cohort.

3.1.2

Successful Randomization

All 17 patients that were recruited into the study were successfully randomized at the
completion of their operation. Because of the integration of the randomization process
into the REDCapTM database management software, physicians and trainees who were
responsible for ensuring randomization occurred at the correct time at the completion of
surgery found the process to be minimally disruptive to the workflow of clinical care in
the operating room.

3.1.3

Point of Care Ultrasound Studies

Point of care ultrasound studies performed at the bedside were stored on a central picture
archiving and communications (PACS) system. Attached to each set of images was a
synoptic reporting form ensuring image assessment addressed each of the findings
defined in the protocol (figure 13). Review of three discrete metrics allowed for an
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Figure 13: Sample POCUS study and accompanying synoptic reporting form identifying
discrete metrics in the study to ensure completeness of image acquisition, interpretation,
and patient allocation.
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assessment of the feasibility of different aspects of executing the POCUS studies.
Successful image completion required adequate physician availability, patient
cooperation, and properly functioning ultrasound devices and information technology
infrastructure. Appropriate image acquisition required that patients have anatomic
ultrasound windows suitable for obtaining the information defined in the protocol,
suitable patient comfort to tolerate ultrasound examinations, as well as physicians
suitably facile in POCUS techniques to acquire the correct images. Finally, successful
image interpretation required an understanding of the physiologic implications of
ultrasound findings and selection of the appropriate fluid resuscitation strategy based on
these findings.
Image Completion
Eight patients in total received POCUS-guided care. Given the trial protocol of five
discrete ultrasound studies, this resulted in forty total ultrasound studies which should
have been completed for this cohort. All forty studies were successfully completed.
Completion was recorded in the PACS system database which allowed for identification
of operator, ultrasound device, study duration, and subsequent quality assurance (QA) of
image acquisition and interpretation (figure 14). Assessment of study duration of these 40
entries showed times ranging between 10 and 20 minutes per study, with longer times
seen at the beginning of the cohort and shorter times seen at the end of the cohort.
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Figure 14: The PACS database identifying study dates, POCUS operators, and reviewer
with ultrasound expertise providing QA. The database records 46 studies instead of 40
due to occasional duplicate study uploads from the portable ultrasound device.
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Image Acquisition
POCUS images were acquired for assessment of the heart, lungs, and IVC in accordance
with the views defined in the study protocol. Review of the studies for quality assurance
by POCUS experts involved grading the acquired images on the following scale: Quality
standards not met, quality standards met with improvements suggested, or quality
standards met with no concerns. 39/40 studies had adequate image acquisition with a
grade of “quality standards met with improvements suggested” or higher. The one
deficient study was in a patient with a pectus deformity who, at the time of the study, was
tachycardic with a heart rate of 120 and experiencing difficulty with post-operative pain
compromising their tolerance for repositioning to optimize image acquisition. As a result,
IVC views obtained were interpretable but the cardiac and lung images were not of
sufficient quality. Given the poor image quality, decisions were made not to alter patient
management until the subsequent study to avoid interpretation errors of poor-quality
images.
Image Interpretation
After image acquisition, studies were reported using a synoptic reporting form to
comment on the findings outlined in the study protocol. Image interpretation was graded
on the same scale used to assess image acquisition. Of the 40 sets of study images
obtained, 40 of them had adequate image acquisition with a grade of “quality standards
met with improvements suggested” or higher. Subjective feedback provided in addition to
the grading of quality allowed POCUS practitioners to refine their understanding of their
findings with the guidance of the QA expert (figure 15).
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Figure 15: An example of the quality assessment and feedback form provided as an
assessment of both the images acquired and the findings of the synoptic report for a given
POCUS study.

3.1.4

Protocol Adherence

Of the cohort of 17 patients recruited, 14 of them had successful protocol adherence
throughout their participation in the study. Three major protocol violations were
identified at various time points in the study. All three violations occurred with patients
randomized to the POCUS group. The first patient received a POCUS study on the
afternoon of post-operative day two that suggested allocation to a fluid-liberal strategy
despite having a trend of resuscitation that had already de-escalated from fluid liberal to
restrictive (Table 3). This was likely the result of patient mobilization and reabsorption of
third-space fluids leading to a decrease in pulmonary edema and ultrasound findings of
fluid overload. As a result, the protocol was violated and the patient remained fluid
restrictive as the POCUS-guided resuscitation strategy contradicted the clinical scenario
otherwise.
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The second patient, also allocated to the POCUS-guided resuscitation arm, received a
fluid bolus in violation of the study protocol. This occurred early on in the study cohort
when physicians were not yet adjusted to the study protocol. A physician responded to a
page from the inpatient ward while in the operating room in the middle of a procedure
and advised to give a fluid bolus to a patient with mild oliguria. The physician recognized
the violation after the operation was complete and contacted research personnel to clarify
the course of events and record the protocol violation.
The third and final protocol violation occurred in a patient who required unplanned
admission to the intensive care unit. Prior to the initiation of the recruitment period, an
extensive education campaign was undertaken with all relevant stakeholders to discuss
the study, its rationale, and the effects it would have at the patient level. This included
research personnel, nursing, leadership directors, and physicians in the intensive care
unit. One group of stakeholders unaccounted for was the junior trainee house staff who
rotated in and out of intensive care on a monthly basis. As a result, when a patient was
transferred to intensive care in the evening the junior house staff were not aware of the
patient’s enrollment in the trial and their crystalloid resuscitation was changed from the
rate as directed by the trial protocol to a different rate based on the junior physician’s
clinical assessment.
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POCUS Study

Resuscitation Strategy

Post-operative recovery room

Fluid liberal

Post-operative day 1 - am

Fluid liberal

Post-operative day 1 - pm

Fluid restrictive

Post-operative day 2 - am

Fluid restrictive

Post-operative day 2 - pm

Fluid liberal – did not make sense given
clinical course – protocol violated

Table 3: Illustration of the resuscitation strategy pathway for a patient allocated to
POCUS-guided resuscitation which resulted in a protocol violation due to disagreement
between ultrasound findings and the patient’s clinical progress.
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3.1.5

Successful Data Collection

A total of 16 out of the 17 patients recruited in the cohort to date had successful data
collection and data entry into the REDCapTM database. One patient did not have their
post-operative serum lactate and CRP lab values entered, which was the result of a
clerical error made with the online ordering system that lead to the lab tests not being
drawn during the required period.

3.1.6

Contamination Rate

None of the patients in this interim cohort had contamination of their allocation by
withdrawal from the study before completion or by crossover from their assigned group
up to final data collection at 30 days after their operation. This is a testament to the
commitment of physicians enrolling their patients in the study, the commitment of
research personnel, and the efforts made to fully inform patients and guide them through
the consent process.

3.2 Clinical Data Collected
Clinical data of the cohort was collected at various times during their inpatient stay.
Given the incomplete recruitment due to Covid-19 pandemic conditions, the data will be
reported in aggregate here. Subsequent publication of the full cohort will display the full
cohort broken down into each treatment group to assist in power and sample size
calculations for a subsequent study examining clinical outcomes.

3.2.1

Intraoperative Data

The majority of patients in the cohort had operations done for aneurysmal disease (82%)
as opposed to occlusive disease (18%). Most patients received epidurals (59%) for postoperative analgesia. Operations lasted an average of 223 minutes measured from first
incision to skin closure. Aortic cross clamp time was an average of 84 minutes, which
included time to placement of the proximal aortic clamp until the time the proximal and
distal clamps were removed and the lower body was reperfused after the aortic
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reconstructions were complete. The average estimated blood loss was 1124mL, but due to
routine cell salvage an average of 441mL of salvaged blood was able to be returned to the
patient by transfusion before the completion of the operation. No patients received
intraoperative bank blood transfusions, and one patient received a bolus of 500mL of 5%
albumin during the course of their operation. The average volume of crystalloid
administered intraoperatively was 4100mL, and the average urine output during the
conduct of the operation was 436mL. A summary of these intraoperative metrics is given
below in table 4.
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Intraoperative Metric

Value

Aortic Pathology
-

Aneurysmal Disease
14 patients (82%)

-

Occlusive disease
3 patients (18%)

Epidural Use

10 patients (59%)

Surgery Duration (mean)

223 minutes

Aortic Crossclamp Time (mean)

84 minutes

Estimated blood loss (mean)

1124 mL

Cell Saver Blood Transfused (mean)

441 mL

Bank Blood Transfused (mean)

0 units

Crystalloid Volume Infused (mean)

0 mL

Colloid Administered (median)

1400 mL

Urine Output (mean)

436 mL

Table 4: Clinical data collected during the course of a patient’s surgery in the operating
room.
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3.2.2

Post-operative Data

In analyzing patient post-operative course, metrics that may be related to altering the
approach to crystalloid resuscitation were collected. Many of these metrics were collected
within the first 48 hours after surgery as this was the time when the approach to
resuscitation was guided by POCUS assessments or by usual care. The average
crystalloid volume given over 48 hours was 9328mL. Assessing serum markers of
inflammation and tissue perfusion, the average peak serum lactate was 2 mmol/L and the
average peak CRP was 173 mg/L. The mean length of stay in hospital was 10 days. Three
patients required vasopressors or inotropes for reasons other than as directed by the
protocol based on POCUS findings. Five patients required post-operative blood product
transfusions with packed red cells, platelets, fresh frozen plasma, or albumin. Four
patients ultimately required unplanned ICU admission with one requiring emergency reoperation for ischemic bowel, and three requiring transfer for acute respiratory failure
requiring invasive or non-invasive positive pressure ventilation. A summary of these
post-operative findings is given below in table 5.
In addition to these clinical metrics, outcomes of major inpatient morbidity and mortality
at 30 days were also collected. The most common morbidity was pulmonary edema in ten
patients, and there was one major mortality at 30 days. A summary of the perioperative
morbidity and mortality metrics is presented in table 6.
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Post-Operative Metric

Value

Crystalloid Volume at 48 hours
Number of Patients Requiring Vasopressor

9328 mL
3 patients (18%)

or inotrope use
Length of Hospital Stay (mean)

10 days

Peak CRP at 24 hours

173 mg/L

Peak Serum Lactate at 24 hours

2 mmol/L

Number of Patients Requiring Blood

5 (29%)

Product Transfusions
Number of Patients Requiring Unplanned

4 (24%)

ICU Admission
Table 5: Clinical data collected during the post-operative patient course. Unless
otherwise specified metrics are collected from time of arrival in the post-operative
recovery room until the time of patient discharge from hospital.
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Major Morbidity/Mortality

Number of Patients (n=17)

Pulmonary Edema

10 (59%)

Cardiac Arrhythmia

5 (29%)

Myocardial Infarction

4 (24%)

Pneumonia

3 (18%)

Acute Kidney Injury

3 (18%)

Ischemic Bowel

2 (18%)

Unplanned Re-operation

2 (12%)

Ischemic Limb

1 (6%)

Death

1 (6%)

Surgical Site Infection

0

Renal Replacement Therapy

0

Table 6: Major inpatient morbidity and mortality metrics measured at up to 30 days after
operation.
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3.2.3

POCUS-Guided Resuscitation Pathways

The PACS system on which images were stored collected objective metrics of heart,
lung, and IVC ultrasound findings on the synoptic reports (table 7). Cardiac views
uniformly demonstrated left ventricular ejection fraction in the normal to moderately
reduced range, with no studies demonstrating severely reduced ejection fraction. No
cardiac studies had image quality poor enough to prevent suitable image interpretation.
Lung views demonstrated a roughly equal mix of A-lines in 53% of studies and B-lines in
47% of studies. No lung studies yielded images poor enough to render them
uninterpretable. IVC views proved to be the most problematic, with uninterpretable views
23% of the time. When views were adequate, IVC diameter in the normal range was the
most common finding in 63% of studies, followed by distended diameter in 10% of
studies, and reduced diameter 3% of the time. Of note, according to the protocol, this
would imply that the IVC yielded a finding that influenced management in only 13% of
the studies completed.
At each discrete time point the results of each organ system assessment were used to
follow the ultrasound resuscitation protocol in figure 10 to determine if the patient should
receive fluid liberal or fluid restrictive resuscitation at that time point. The results of each
ultrasound metric for the eight patients randomized to POCUS-guided resuscitation are
outlined in table 8.
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POCUS Metric

Number of Results (n = 40)

Cardiac Findings
-

Normal EF (50-70%)
35 (88%)

-

Moderately Reduced EF (30-50%)
5 (12%)

-

Severely Reduced EF (<30%)
0

-

Indeterminate
0

Lung Findings
-

A-lines – suggested of well aerated
lung

21 (53%)

-

B-lines – suggestive of parenchymal
disease, likely pulmonary edema

19 (47%)

-

Indeterminate
0

IVC Findings
-

Distended (>2.5cm)
4 (10%)

-

Normal (1.5 - 2.5cm)
25 (63%)

-

Reduced size (<1.5 cm)
1 (3%)

-

Intubated – Respiratory Variation
assessed
Indeterminate

0
9 (23%)

Table 7: Ultrasound findings for heart, lung, and IVC assessments
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Patient Post-Operative
ID

POD #1 - am

POD #1 - pm

POD #2 - am

POD #2 - pm

Recovery Room
1

Liberal

Liberal

Restrictive

Restrictive

Restrictive

2

Liberal

Liberal

Liberal

Liberal

Restrictive

3

Liberal

Liberal

Liberal

Restrictive

Restrictive

4

Liberal

Liberal

Liberal

Restrictive

Restrictive

5

Liberal

Liberal

Restrictive

Restrictive

Restrictive

6

Liberal

Liberal

Restrictive

Restrictive

Restrictive

7

Liberal

Liberal

Restrictive

Restrictive

Restrictive

8

Liberal

Restrictive

Restrictive

Restrictive

Restrictive

Table 8: Resuscitation strategies chosen at each POCUS assessment for the patients
randomized to POCUS-guided resuscitation.
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Chapter 4

4

Discussion

Review of the feasibility outcomes to date have shown that the design of the study has
potential to achieve feasibility in the full cohort, and clinical data have demonstrated
results that show promise in informing development of clinical outcomes as well as
power calculations and sample size estimates for future research studies. Furthermore,
review of the instances where specific feasibility metrics were not met have identified
areas for improvement in the protocol and execution of the study for future stages of this
research program. Due to the Covid-19 pandemic this data set represents and interim
analysis, and we anticipate further valuable insight will emerge with recruitment of the
full cohort.
When considering the primary outcomes examining feasibility, it is important to evaluate
them keeping in mind that the aim of a feasibility study is to determine the viability of
executing a study as designed. Assessment of a given feasibility outcome can be grossly
categorized as feasible with no modification, feasible but requires modification or
adjustment, and not likely to be feasible. Review of the interim assessment of feasibility
in the cohort recruited to date shows that the protocol as designed is generally feasible
with some specific areas to consider revision pending the final cohort.
The recruitment consent rate of 89% shows that the rate of recruitment has potential to
remain feasible in the final cohort. This speaks to the quality of informed consent
obtained by the physicians and research personnel involved in the study, and it suggests
the consent form and letter of information succeed in making patients feel comfortable
participating in the study. Assuming this interim cohort is representative of the final
population of 40 patients, this will result in a recruitment rate meeting the average
expected recruitment rate estimated in the trial design (figure 11). If most candidates who
meet the inclusion criteria and lack the exclusion criteria designed in the study are
successful recruited into the study, this implies that yearly case volumes at a given center
can be used in concert with sample size calculations as a reasonable estimation of
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whether or not a full study can be completed at a single center in a reasonable amount of
time or whether a multi-center trial would be needed to recruit the target cohort in a
reasonable timeframe.
Successful randomization of 100% of the patients in the study recruited to date is a
reassuring commentary on the design of the randomization process. Using digital tools
accessible by computer or mobile device to randomize patients as opposed to a sealed
envelope or other physical randomization tool allows for a decentralized and easily
accessible process. Since randomization has been designed to take place at the end of an
operation when room turnover, transfer of patients from the operating room to the postoperative recovery room, and finalization of post-operative orders are taking place, these
tasks all have potential to divert attention away from initiation of randomization in a
clinical trial. The trend of uniformly successful randomization suggests that the
streamlined randomization process offered by our digital tool is suitable for convenient
randomization in this clinical environment.
The POCUS metrics have shown trends toward feasibility in each component evaluated.
Firstly, the successful completion of POCUS studies has been 100% successful in the
interim cohort. This is a commentary on both human and technological factors in the
study design. Given that these ultrasound assessments are done in a clinically busy
environment with many competing demands, it is reassuring that the implementation of
POCUS assessments into the clinical workflow of surgical trainees has not been so
disruptive as to prohibit their completion in a suitable time. With study times starting at
30 minutes and eventually decreasing to as low as 10 minutes, this also reinforces the
value of POCUS as a physician-lead augmentation of patient assessment at the bedside.
Finally, the successful completion of studies also required the portable ultrasound
technology to perform reliably in a consistent manner. Simple failures such as discharged
batteries in portable ultrasound devices, network connectivity issues prohibiting
transmission of information to the central PACS reporting system, or malfunction of
ultrasound probes could potentially marginalize the successful execution of the study, and
thankfully there have been no such technological barriers thus far.
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POCUS image quality and image interpretation were judged to be adequate in 98% and
100% of studies respectively. This speaks to the design of the ultrasound protocol as well
as the accessibility of POCUS skills to the personnel involved. These ultrasound
examinations were performed by surgical trainees with previous experience in vascular
ultrasound as well as the focused assessment with sonography in trauma (FAST) exam.
With specific training and orientation including video modules, supervised practice
ultrasound exams, and mentored POCUS exams on patients centered around the views of
the heart, lung, and IVC used in the study they were able to successfully acquire and
interpret images with extremely high rates of success. Limiting the study protocol to Bmode images without advanced doppler studies or quantitative hemodynamic
assessments was done to decrease the amount of training required to acquire and interpret
the images successfully while still being able to acquire information suitable to make
clinical decisions about resuscitation. Beyond this specific feasibility metric, we did
identify that the IVC diameter was the most frequently unreliable ultrasound metric, and
it was a metric responsible for a change in resuscitation strategy only 13% of the time. It
may be reasonable to consider eliminating the IVC diameter assessment in the trial
protocol should this trend continue to be displayed in the final cohort.
The rate of protocol adherence was 82% in the interim cohort recruited to date, which
represents three major protocol violations. These violations were due to three unique
scenarios unanticipated in the design of the study and the preparation of its execution.
With a metric close to the pre-defined threshold of feasibility, this suggests a trend
toward feasibility requiring modification before execution of a final study. The specific
adjustments that would aid in avoiding future protocol violations will be discussed in
association with each protocol violation identified. The first violation occurred when the
POCUS exam suggested the patient should receive fluid liberal resuscitation, despite the
fact that their clinical trajectory saw de-escalating fluid requirements in the preceding 24
hours. This likely occurred as a result of the patient receiving appropriately targeted
resuscitation with early de-escalation, and as a result their final POCUS exam in the
afternoon of post-operative day 2 showed no signs of fluid overload. This discordance
between the protocol’s instruction and what was deemed clinically appropriate points out
a flaw identified in the trial protocol. A revision to the protocol could be made such that
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when patients transition from a fluid liberal to a fluid restrictive approach they continue
on that trajectory until the need for IV fluids is no longer required. Further consideration
could be given to the possibility of using the transition from fluid liberal to fluid
restrictive resuscitation as a trigger to terminate future POCUS exams as the clinical
likelihood of requiring a transition back to fluid liberal resuscitation as time progresses is
very low. The second protocol violation occurred early on when a patient randomized to
the POCUS arm received a fluid bolus in violation of the study protocol. This occurred
very early on in the patient cohort before providers had grown accustomed to the
protocol, and furthermore the order was given from a provider in the operating room with
cognitive load from the operation being performed rendering them less available to recall
the patient’s involvement in the study. Making efforts to avoid contacting providers
actively participating in operations to make clinical decisions about study patients would
assist in minimizing repeat protocol violations of this kind. The last protocol violation
occurred when a patient with unplanned admission to the ICU received resuscitation and
management that were not in keeping with the study’s protocol. This was a failure of
education of all relevant stakeholders in execution of the study. Despite focusing on a
hospital-wide education campaign prior to initiation of the study, intensive care unit
junior house staff were not included in the relevant stakeholders involved in this
education campaign. Preventing further protocol violations of this kind will be
accomplished by explicit review of the trial protocol with ICU junior trainees upon
transfer of patients, as well as a diligent review of any possible stakeholders in patient
care to ensure other groups are not left uninformed of the study and its protocol.
Data collection was successful in 94% of the interim cohort. One patient did not have
their post-operative serum lactate lab values entered due to a clerical error with the
ordering system in the e-health record. This clerical error was addressed by revising the
comprehensive care set of orders constructed for patients enrolled in the study, and no
further issues with collection of lab samples occurred. The high rate of success of data
collection is likely the result of the electronic health record as well as the electronic
REDCapTM database used in the design of the study. This allowed researchers to use any
computer terminal or secure mobile device to review relevant clinical data and enter it
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into the database, which negated the need for visits to a central health records location to
manually review paper charts to abstract data.
The contamination rate was 0% in the interim cohort. This indicates that no patient or
physician motivators resulted in patients being withdrawn from the study or crossed over
from their randomized group to the opposite arm of the study. From a patient perspective,
efforts made to set expectations during the initial consent process and by use of the
consent form and letter of information likely helped to minimize patient desire to
withdraw from the study. Additionally, it highlights a high degree of patient compliance
with POCUS exams as factors such as patient discomfort or inconvenience would
possibly contribute to patient desire to cease involvement in the study prematurely. From
a physician perspective, it highlights the commitment of the vascular surgeons willing to
enroll their patients in the study and allow an experimental protocol to deviate from their
usual approach to patient care.
Beyond the feasibility metrics, the clinical data collected has been promising. Rates of
perioperative morbidity and mortality approach those outlined in previous population
studies. Although the data to date is reported in aggregate given the incomplete
recruitment of this cohort, reporting the final cohort with clinical endpoints separated into
the two arms of the study has the potential to identify multiple possible metrics to
consider as primary and secondary outcomes.

4.1 Study Limitations
An obvious limitation of this study to date is the incompletely recruited cohort. This is an
unfortunate side effect of the Covid-19 pandemic, and we are fully committed to final
recruitment of the planned cohort once full clinical and research activities resume at our
institution. Beyond this primary limitation, there are some other specific issues we have
identified.
Feasibility studies carry with them their own specific limitations. While they make good
methodological sense in a study such as this which explores a specific intervention that
has a paucity of previously published studies and has potential for barriers to execution,
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the only objective conclusions that can be drawn from them is whether or not the protocol
itself is practical to execute as designed. Should this study prove to be feasible in the final
cohort, this first step in the research program will in fact allow for a more effective
successful implementation of a subsequent study designed to detect statistical
significance in clinical endpoints.
There are also a number of limitations in the physiologic assumptions made by the
POCUS metrics used in the trial protocol. Firstly, the simplicity of B-mode assessment of
left ventricular ejection fraction is limited when compared to the more advanced and
objective assessment of cardiac output using ultrasound pulse-wave doppler of the left
ventricular outflow tract. In the absence of an objective metric of decreased cardiac
output to connect hypotension to poor cardiac pump function, the assumption being made
is that significant volume loading in a patient with a severely decreased left ventricular
ejection fraction has significant risk of acute heart failure, and a volume-sparing approach
with vasopressors and inotropes is a safer way to address hypotension in this population.
Another assumption being made is that the accumulation of B-lines on lung ultrasound is
a reasonable metric of volume overload in this patient population. While no studies have
specifically examined this correlation, there is sound physiologic basis to the argument
that sonographic identification of pulmonary edema should factor into the approach to
crystalloid resuscitation.
The quality assurance process in reviewing POCUS studies also carries with it a potential
limitation in that it is inherently subjective. While experts with certification in point of
care ultrasound may generally agree on the findings of a given exam or set of images, the
criteria for defining images as adequately acquired or interpreted is more subjective. We
attempted to minimize the effect of this by designating a single expert with certification
in both POCUS and advanced critical care echocardiography to grade the images for
acquisition and interpretation. This may be more difficult to control if the study
progresses to a trial designed for clinical significance if it is held at multiple sites or at a
single site that requires a long period of recruitment. There is, however, potential for this
limitation to be addressed with technology. Progression in portable POCUS technology
has led to the development of artificial intelligence-based tools to grade the quality of an
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image compared to a desired standard view a user is attempting to obtain (figure 16), and
multiple providers have created remote tele-mentoring systems that allow a single
centrally-located provider to directly observe live acquisition of POCUS exams to guide a
user in real-time (figure 17). These technological advancements may allow for a more
consistent centrally-located expert to remain the single provider of QA and study
feedback.

Figure 16: Artificial Intelligence (AI) interpretation of a parasternal long axis view of the
heart. The left depicts a low-quality image as interpreted by the AI, and the right depicts a
more optimized high-quality image.
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Figure 17: Remote teleguidance system provided by the Butterfly Network POCUS
device platform. Real-time guidance is being given to optimize the location of the
ultrasound probe to acquire lung ultrasound images.
Source: https://www.butterflynetwork.com/enca/teleguidance. Accessed July 31, 2020.
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4.2 Conclusion
In conclusion, this study has used a novel approach of utilizing POCUS technology to
establish a protocol for goal-directed resuscitation of patients receiving open abdominal
aortic surgery. While the cohort has been incompletely recruited to due to the Covid-19
pandemic, early results are promising showing trends towards feasibility for all of the
pre-defined primary outcomes. Lessons have been learned to date that will be valuable in
modifying and streamlining implementation of the study in a subsequent trial powered to
detect statistical significance in clinical outcomes. Pending final data from the full cohort,
there may be revisions made to the trial to address concerns identified in the feasibility
trial to date before proceeding with the next stage of this research program.
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